PF-Atlas › Mechanisms › R-spondin 3 expands AEC2 stem cell pool via WNT pathway

R-spondin 3 expands AEC2 stem cell pool via WNT pathway in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

R-spondin 3 expands AEC2 stem cell pool via WNT pathway is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.

Drugs targeting R-spondin 3 expands AEC2 stem cell pool via WNT pathway

WNT

Therapies

WNT/RSPO3 Agonist

Medical disclaimer. This is a research summary, not medical advice.